LONGITUDINAL MICROPERIMETRY EVALUATION AFTER INTRAVITREAL OCRIPLASMIN INJECTION FOR VITREOMACULAR TRACTION.
Macular Diseases
Related content
COMMENTED
Macular Diseases
Morphological Reconstitution and Persistent Changes After Intravitreal Ocriplasmin for Vitreomacular Traction and Macular Hole
★ 1
Recommended by
Prof. Dr Daniel Barthelmes, Faculty Member
★ 2
Recommended and commented by
Dr habil. Gábor Márk Somfai, PhD, Faculty Member
J Ocul Pharmacol Ther.
Zandi S, Freiberg F, Vaclavik V, Pfister IB, Traine PG, Kaya C, Michels S, Garweg JG
doi: 10.1089/jop.2019.0051.
Surgery and Intervention
COMPARISON OF RESOLUTION OF VITREOMACULAR TRACTION AFTER OCRIPLASMIN TREATMENT OR VITRECTOMY
Retina.
Scholz P, Sitnilska V, Hess J, Becker M, Michels S, Fauser S
doi: 10.1097/IAE.
Macular Diseases
Longitudinal ellipsoid zone and subretinal fluid mapping following ocriplasmin injection in the prospective observational ORBIT trial
Br J Ophthalmol.
Lavine JA, Srivastava SK, Dukles N, Reese JL, Ehlers JP
doi: 10.1136/bjophthalmol-
Surgery and Intervention
Association of Intravitreal Injections With Blood Pressure Increase: The Following Excitement and Anxiety Response Under Intravitreal Injection Study
JAMA Ophthalmol.
Berger V, Munk MR, Lersch F, Wolf S, Ebneter A, Zinkernagel MS
doi: 10.1001/jamaophthalmol.
Macular DiseasesRetinal Diseases
Results of the 2-Year Ocriplasmin for Treatment for Symptomatic Vitreomacular Adhesion Including Macular Hole (OASIS) Randomized Trial
Ophthalmology.
Dugel PU, Tolentino M, Feiner L, Kozma P, Leroy A
doi: 10.1016/j.ophtha.2016.06.043.
Macular DiseasesRetinal Diseases
Vitreomacular adhesion or vitreomacular traction may affect antivascular endothelium growth factor treatment for neovascular age-related macular degeneration
Br J Ophthalmol.
Xie P, Zheng X, Yu Y, Ye X, Hu Z, Yuan D, Liu Q
doi: 10.1136/bjophthalmol-
RECOMMENDED
Retinal Diseases
The Impact of Prefilled Syringes on Endophthalmitis following Intravitreal Injection of Ranibizumab
Am J Ophthalmol.
Storey PP, Tauqeer Z, Yonekawa Y, Todorich B, Wolfe JD, Shah SP, Shah AR, Koto T, Abbey AM Morizane Y, Sharma P, Wood EH, Morizane-Hosokawa M, Pendri P, Pancholy M, Harkey S, Jeng-Miller KW, Obeid A, Borkar DS, Chen E, Williams P, Okada AA, Inoue M, Shiraga F, Hirakata A, Shah CP, Prenner J, Garg S; for the; Post-Injection Endophthalmitis (PIE) Study Group
doi: 10.1016/j.ajo.2018.11.023.
Macular Diseases
Observation of curative effect of intravitreal injection of conbercept in wet age-related macular degeneration: Optical coherence tomography analysis after injection
Microsc Res Tech.
Yang W, Tan Y, Li C, Liu Y, Lu G
doi: 10.1002/jemt.22989.
COMMENTED
Retinal Diseases
Multicentre study of 4626 patients assesses the effectiveness, safety and burden of two categories of treatments for central retinal vein occlusion: intravitreal anti-vascular endothelial growth factor injections and intravitreal Ozurdex injections
★ 2
Recommended and commented by
Dr habil. Gábor Márk Somfai, PhD, Faculty Member
Br J Ophthalmol
Gale R, Gill C, Pikoula M, Lee AY, Hanson RLW, Denaxas S, Egan C, Tufail A, Taylor P, UK EMR Database Users Group.
doi: 10.1136/bjophthalmol-2020-317306